Treatment of loin pain suspected to be renal colic with papaverine hydrochloride: a prospective double-blind randomised study
Article first published online: 20 FEB 2012
© 2012 BJU INTERNATIONAL
Volume 110, Issue 3, pages 449–452, August 2012
How to Cite
Asgari, S. A., Asli, M. M., Madani, A. H., Maghsoudi, P. A., Ghanaei, M. M., Shakiba, M., Aval, H. B., Enshaei, A., Farzan, A. and Esmaeili, S. (2012), Treatment of loin pain suspected to be renal colic with papaverine hydrochloride: a prospective double-blind randomised study. BJU International, 110: 449–452. doi: 10.1111/j.1464-410X.2011.10793.x
- Issue published online: 10 JUL 2012
- Article first published online: 20 FEB 2012
- Accepted for publication 17 August 2011
- renal colic;
- pain relief
Study Type – Therapy (RCT)
Level of Evidence 1b
What's known on the subject? and What does the study add?
Results of our study showed that intravenous papaverine hydrochloride plus suppository sodium diclofenac were more effective than diclofenac sodium suppository alone in the treatment of acute renal colic. Therefore, intravenous papaverine hydrochloride may be a beneficial supplemental therapy to relieve renal colic pain, particularly in combination with NSAIDs.
- • To assess the efficacy of papaverine hydrochloride combined with a diclofenac sodium suppository to relieve renal colic compared with diclofenac suppository monotherapy, as the effect of phosphodiesterase inhibitors on ureteric muscles might reduce the pain of renal colic.
PATIENTS AND METHODS
- • A prospective, double-blind clinical study was performed.
- • In all, 550 patients aged 17–55 years with acute renal colic were randomised to two groups. Patients in one group (group A) received a diclofenac suppository (100 mg) plus saline 0.9% (placebo) and the other group (group B) received a diclofenac suppository (100 mg) plus intravenous (i.v.) papaverine hydrochloride (1.5 mg/kg up to120 mg).
- • Pain intensity was assessed using a visual analogue scale (VAS) at 0, 20 and 40 min after treatment. Further analgesia was provided at the patients' request (25 mg pethidine intramuscularly).
- • Baseline characteristics (sex, age, past history of similar pains) were similar in the two groups.
- • There were significant differences in VAS pain scores between 0 and 20 min and 0 and 40 min in both groups (P < 0.001).
- • At the end of study, 71.1% of patients in group A and 90.9% of patients in group B reported pain relief and did not require pethidine, respectively.
- • Significantly more patients in group A required further analgesia.
- • According to our results, i.v. papaverine hydrochloride plus a diclofenac suppository were more effective than the diclofenac suppository alone for treating acute renal colic.
- • Therefore, i.v. papaverine hydrochloride is a beneficial supplemental therapy to relieve renal colic pain, particularly combined with non-steroidal anti-inflammatory drugs.